NCT05175664View on ClinicalTrials.gov

Novel Diagnostic and Disease Stage Biomarkers in AD

CompletedOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2024

Conditions
Alzheimer DiseaseMild Cognitive ImpairmentNeuro-Degenerative DiseasesVascular DementiaDementia With Lewy BodiesHealthy Controls
Interventions
OTHER

Long-term study

No intervention. Investigations: cognitive tests, blood samples, pupillometry, actigraphy, and FDG-PET/MR brain scan.

OTHER

Short-term study

No intervention. Investigations: blood samples and pupillometry.

OTHER

Cross-sectional study

No intervention. Investigations: cognitive tests, pupillometry and actigraphy.

Trial Locations (1)

2100

Danish Dementia Research Centre, Copenhagen

All Listed Sponsors
lead

Danish Dementia Research Centre

NETWORK

NCT05175664 - Novel Diagnostic and Disease Stage Biomarkers in AD | Biotech Hunter | Biotech Hunter